Connection

Stephen Kent to Animals

This is a "connection" page, showing publications Stephen Kent has written about Animals.
Connection Strength

0.303
  1. Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity. Adv Healthc Mater. 2021 05; 10(10):e2002142.
    View in: PubMed
    Score: 0.027
  2. Moving the HIV vaccine field forward: concepts of protective immunity. Lancet HIV. 2019 06; 6(6):e406-e410.
    View in: PubMed
    Score: 0.024
  3. Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies. Retrovirology. 2018 08 22; 15(1):58.
    View in: PubMed
    Score: 0.023
  4. Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection. Viruses. 2018 06 18; 10(6).
    View in: PubMed
    Score: 0.023
  5. Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization? Curr Opin HIV AIDS. 2018 03; 13(2):160-166.
    View in: PubMed
    Score: 0.022
  6. HIV Reactivation after Partial Protection by Neutralizing Antibodies. Trends Immunol. 2018 05; 39(5):359-366.
    View in: PubMed
    Score: 0.022
  7. Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection. Sci Transl Med. 2017 Aug 09; 9(402).
    View in: PubMed
    Score: 0.021
  8. Antibody-dependent cellular cytotoxicity and influenza virus. Curr Opin Virol. 2017 02; 22:89-96.
    View in: PubMed
    Score: 0.021
  9. Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques. Virology. 2008 May 10; 374(2):528-34.
    View in: PubMed
    Score: 0.011
  10. Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice. Proc Natl Acad Sci U S A. 2021 05 11; 118(19).
    View in: PubMed
    Score: 0.007
  11. Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques. Nat Commun. 2021 03 03; 12(1):1403.
    View in: PubMed
    Score: 0.007
  12. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nat Rev Immunol. 2020 12; 20(12):727-738.
    View in: PubMed
    Score: 0.007
  13. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020 10; 5(10):1185-1191.
    View in: PubMed
    Score: 0.007
  14. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. 2020 09; 26(9):1428-1434.
    View in: PubMed
    Score: 0.007
  15. Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of In Vitro versus In Vivo Models. J Virol. 2019 06 01; 93(11).
    View in: PubMed
    Score: 0.006
  16. Inducible Bronchus-Associated Lymphoid Tissues (iBALT) Serve as Sites of B Cell Selection and Maturation Following Influenza Infection in Mice. Front Immunol. 2019; 10:611.
    View in: PubMed
    Score: 0.006
  17. Immunological basis for enhanced immunity of nanoparticle vaccines. Expert Rev Vaccines. 2019 03; 18(3):269-280.
    View in: PubMed
    Score: 0.006
  18. Minimum information reporting in bio-nano experimental literature. Nat Nanotechnol. 2018 09; 13(9):777-785.
    View in: PubMed
    Score: 0.006
  19. The Multifaceted Nature of Immunoglobulin A and Its Complex Role in HIV. AIDS Res Hum Retroviruses. 2018 09; 34(9):727-738.
    View in: PubMed
    Score: 0.006
  20. The Rare Anaphylaxis-Associated Fc?RIIa3 Exhibits Distinct Characteristics From the Canonical Fc?RIIa1. Front Immunol. 2018; 9:1809.
    View in: PubMed
    Score: 0.006
  21. A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun. 2018 07 10; 9(1):2669.
    View in: PubMed
    Score: 0.006
  22. Templated Polymer Replica Nanoparticles to Facilitate Assessment of Material-Dependent Pharmacokinetics and Biodistribution. ACS Appl Mater Interfaces. 2017 Oct 04; 9(39):33683-33694.
    View in: PubMed
    Score: 0.005
  23. Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection. EBioMedicine. 2017 May; 19:119-127.
    View in: PubMed
    Score: 0.005
  24. Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery. ACS Nano. 2017 01 24; 11(1):54-68.
    View in: PubMed
    Score: 0.005
  25. Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field. Curr HIV Res. 2017; 15(3):202-215.
    View in: PubMed
    Score: 0.005
  26. Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses. Vaccine. 2016 Feb 24; 34(9):1172-9.
    View in: PubMed
    Score: 0.005
  27. Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates. Eur J Immunol. 2015 Mar; 45(3):854-64.
    View in: PubMed
    Score: 0.004
  28. Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques. J Virol. 2011 Sep; 85(17):9167-75.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.